Krystal Biotech Ownership 2024 | Who Owns Krystal Biotech Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

13.01%

Insider Ownership

12.32%

Retail Ownership

74.68%

Institutional Holders

94.00

Krystal Biotech Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FMR LLC15.14%0.05%4,283,76639,8740.94%786,670,788Jun 30, 2024
BLACKROCK INC.13.95%0.02%3,947,8452,142,466118.67%724,982,257Jun 30, 2024
VANGUARD GROUP INC10.14%0.01%2,869,136436,35717.94%526,888,136Jun 30, 2024
AVORO CAPITAL ADVISORS LLC8.60%5.95%2,433,000-122,555-4.80%446,796,120Jun 30, 2024
STATE STREET CORP4.71%0.01%1,332,875388,32841.11%244,769,165,000Jun 30, 2024
REDMILE GROUP, LLC3.61%11.34%1,021,078-487,172-32.30%187,510,764Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.3.49%8.49%988,460--181,520,794Jun 30, 2024
CAPITAL WORLD INVESTORS3.10%0.03%878,158781,011803.95%161,264,935Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/2.12%0.01%600,145-58,473-8.88%110,212,000Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP2.05%0.03%580,4527,5371.32%106,593,430Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.05%0.01%580,22054,47510.36%106,572,417Jun 30, 2024
HOOD RIVER CAPITAL MANAGEMENT LLC1.84%1.98%521,09325,5075.15%95,693,519Jun 30, 2024
JENNISON ASSOCIATES LLC1.84%0.06%520,390-150,345-22.41%95,564,419Jun 30, 2024
GOLDMAN SACHS GROUP INC1.49%0.01%422,331-12,243-2.82%77,556,865Jun 30, 2024
LORD, ABBETT & CO. LLC1.39%0.24%392,238-99,994-20.31%72,030,000Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC1.19%0.02%336,1705,7281.73%61,734,259Jun 30, 2024
MORGAN STANLEY1.13%0.00%318,32799,49845.47%58,457,570Jun 30, 2024
WOODLINE PARTNERS LP1.03%0.51%291,91816,4635.98%53,607,822Jun 30, 2024
INVESCO LTD.0.97%0.01%275,077185,449206.91%50,515,140Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC0.89%0.01%251,762233,5011278.69%46,233,575Jun 30, 2024

Krystal Biotech's largest institutional shareholder is FMR LLC, holding 15.14% of the company's total share outstanding, currently valued at $786.67M. The top 10 institutional shareholders own together 66.92% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
REDMILE GROUP, LLC3.61%11.34%1,021,078-487,172-32.30%187,510,764Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.3.49%8.49%988,460--181,520,794Jun 30, 2024
S SQUARED TECHNOLOGY, LLC0.30%6.91%85,215-5,000-5.54%15,648,883Jun 30, 2024
AVORO CAPITAL ADVISORS LLC8.60%5.95%2,433,000-122,555-4.80%446,796,120Jun 30, 2024
DECHENG CAPITAL LLC0.23%3.70%65,772--12,078,370Jun 30, 2024
FIRST TURN MANAGEMENT, LLC0.39%3.26%109,222-21,628-16.53%20,057,528Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.45%2.04%126,00041,90049.82%23,138,640Jun 30, 2024
HOOD RIVER CAPITAL MANAGEMENT LLC1.84%1.98%521,09325,5075.15%95,693,519Jun 30, 2024
EVOLUTIONARY TREE CAPITAL MANAGEMENT, LLC0.03%1.69%8,935-161-1.77%1,640,823Jun 30, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC0.30%1.48%85,0005,0006.25%15,609,400Jun 30, 2024
EAM GLOBAL INVESTORS LLC0.10%1.19%28,84310.00%5,296,729Jun 30, 2024
REDWOOD INVESTMENTS, LLC0.05%0.87%13,9295,67768.80%2,541,761Jun 30, 2024
HEALTHINVEST PARTNERS AB0.03%0.85%7,6241,00015.10%1,400,071Jun 30, 2024
EAM INVESTORS, LLC0.09%0.78%26,284-151-0.57%4,826,794Jun 30, 2024
BRAIDWELL LP0.38%0.62%107,179-69,910-39.48%19,682,352Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.37%0.58%105,5691,6001.54%19,386,691Jun 30, 2024
WOODLINE PARTNERS LP1.03%0.51%291,91816,4635.98%53,607,822Jun 30, 2024
GHOST TREE CAPITAL, LLC0.03%0.49%8,500-5,500-39.29%1,560,940Jun 30, 2024
OBERWEIS ASSET MANAGEMENT INC/0.15%0.48%42,6006,90019.33%7,823,064Jun 30, 2024
QUANTUM PRIVATE WEALTH, LLC0.03%0.47%7,205--1,323,127Jun 30, 2024

The largest Krystal Biotech shareholder by % of total assets is REDMILE GROUP, LLC. The company owns 1.02M shares of Krystal Biotech (KRYS), representing 11.34% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.13.95%0.02%3,947,8452,142,466118.67%724,982,257Jun 30, 2024
CAPITAL WORLD INVESTORS3.10%0.03%878,158781,011803.95%161,264,935Jun 30, 2024
VANGUARD GROUP INC10.14%0.01%2,869,136436,35717.94%526,888,136Jun 30, 2024
STATE STREET CORP4.71%0.01%1,332,875388,32841.11%244,769,165,000Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC0.89%0.01%251,762233,5011278.69%46,233,575Jun 30, 2024
INVESCO LTD.0.97%0.01%275,077185,449206.91%50,515,140Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC0.44%0.01%123,469117,5101971.98%22,673,848,000Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.68%0.01%193,767103,928115.68%35,583,435Jun 30, 2024
MORGAN STANLEY1.13%0.00%318,32799,49845.47%58,457,570Jun 30, 2024
EAGLE ASSET MANAGEMENT INC0.27%0.07%76,25976,259100.00%13,899,727Jun 30, 2024
AMERIPRISE FINANCIAL INC0.36%0.01%101,99658,605135.06%18,730,546Jun 30, 2024
CAPTION MANAGEMENT, LLC0.28%0.22%78,70056,300251.34%14,452,468Jun 30, 2024
PUBLIC SECTOR PENSION INVESTMENT BOARD0.19%0.06%54,65654,656100.00%10,037,028Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.05%0.01%580,22054,47510.36%106,572,417Jun 30, 2024
FRANKLIN RESOURCES INC0.64%0.01%181,58250,11738.12%33,345,719Jun 30, 2024
LEGAL & GENERAL GROUP PLC0.23%0.00%66,10346,553238.12%12,139,155Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.45%2.04%126,00041,90049.82%23,138,640Jun 30, 2024
FMR LLC15.14%0.05%4,283,76639,8740.94%786,670,788Jun 30, 2024
RHUMBLINE ADVISERS0.25%0.01%71,68539,586123.32%13,164,211Jun 30, 2024
SEGALL BRYANT & HAMILL, LLC0.12%0.11%34,73734,737100.00%6,379,103Jun 30, 2024

As of Jun 30 2024, Krystal Biotech's largest institutional buyer is BLACKROCK INC.. The company purchased 2.14M stocks of KRYS, valued at $724.98M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
REDMILE GROUP, LLC3.61%11.34%1,021,078-487,172-32.30%187,510,764Jun 30, 2024
IKARIAN CAPITAL, LLC----375,000-100.00%-Jun 30, 2024
JENNISON ASSOCIATES LLC1.84%0.06%520,390-150,345-22.41%95,564,419Jun 30, 2024
AVORO CAPITAL ADVISORS LLC8.60%5.95%2,433,000-122,555-4.80%446,796,120Jun 30, 2024
LORD, ABBETT & CO. LLC1.39%0.24%392,238-99,994-20.31%72,030,000Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.03%0.04%9,700-93,100-90.56%1,781,308Jun 30, 2024
D. E. SHAW & CO., INC.0.04%0.00%11,046-70,981-86.53%2,028,487Jun 30, 2024
BRAIDWELL LP0.38%0.62%107,179-69,910-39.48%19,682,352Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.0.21%0.02%59,810-64,393-51.84%10,983,508Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/2.12%0.01%600,145-58,473-8.88%110,212,000Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.01%0.00%2,570-54,065-95.46%471,955Jun 30, 2024
VESTAL POINT CAPITAL, LP----45,000-100.00%-Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.06%0.02%17,989-43,811-70.89%3,303,500Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC----26,746-100.00%-Jun 30, 2024
MAN GROUP PLC0.24%0.03%69,250-26,608-27.76%12,717,070Jun 30, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)0.68%0.17%191,515-26,232-12.05%35,169,815Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----24,700-100.00%-Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC----24,000-100.00%-Jun 30, 2024
UBS GROUP AG0.10%0.00%28,556-22,472-44.04%5,244,024Jun 30, 2024
FIRST TURN MANAGEMENT, LLC0.39%3.26%109,222-21,628-16.53%20,057,528Jun 30, 2024

As of Jun 30 2024, Krystal Biotech's biggest institutional seller is REDMILE GROUP, LLC. The company sold -0.49M shares of KRYS, valued at $187.51M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
EAGLE ASSET MANAGEMENT INC0.27%0.07%76,25976,259100.00%13,899,727Jun 30, 2024
PUBLIC SECTOR PENSION INVESTMENT BOARD0.19%0.06%54,65654,656100.00%10,037,028Jun 30, 2024
SEGALL BRYANT & HAMILL, LLC0.12%0.11%34,73734,737100.00%6,379,103Jun 30, 2024
ALPS ADVISORS INC0.08%0.03%22,27022,270100.00%4,089,663Jun 30, 2024
HILLSDALE INVESTMENT MANAGEMENT INC.0.07%0.30%21,00021,000100.00%3,856,440Jun 30, 2024
THRIVENT FINANCIAL FOR LUTHERANS0.07%0.01%20,62520,625100.00%3,788,000Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.0.05%0.00%15,00015,000100.00%2,754,600Jun 30, 2024
NEW YORK STATE TEACHERS RETIREMENT SYSTEM0.05%0.01%14,90014,900100.00%2,736,000Jun 30, 2024
STATE OF ALASKA, DEPARTMENT OF REVENUE0.05%0.03%14,58714,587100.00%2,678,000Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.05%0.01%14,39014,390100.00%2,642,580Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.04%0.01%12,59412,594100.00%2,311,550Jun 30, 2024
LOUISIANA STATE EMPLOYEES RETIREMENT SYSTEM0.04%0.04%12,50012,500100.00%2,295,500Jun 30, 2024
NORGES BANK0.04%0.00%11,34011,340100.00%2,082,478Jun 30, 2024
YOUSIF CAPITAL MANAGEMENT, LLC0.04%0.02%10,10410,104100.00%1,855,499Jun 30, 2024
MARYLAND STATE RETIREMENT & PENSION SYSTEM0.03%0.03%8,6638,663100.00%1,590,873Jun 30, 2024
OREGON PUBLIC EMPLOYEES RETIREMENT FUND0.02%0.02%6,0306,030100.00%1,107,349Jun 30, 2024
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS0.02%0.01%5,3545,354100.00%983,209Jun 30, 2024
WINTON GROUP LTD0.02%0.06%4,9614,961100.00%911,038Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.01%0.04%3,9003,900100.00%716,196Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.01%0.00%3,6003,600100.00%661,104Jun 30, 2024
WALLEYE CAPITAL LLC0.01%0.00%3,3003,300100.00%606,012Jun 30, 2024
BANK OF MONTREAL /CAN/0.01%0.00%2,9362,936100.00%539,666Jun 30, 2024
RAYMOND JAMES & ASSOCIATES0.01%0.00%2,8292,829100.00%519,518Jun 30, 2024
CAPULA MANAGEMENT LTD0.01%0.00%2,4042,404100.00%441,471Jun 30, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.0.01%0.01%2,3792,379100.00%436,880Jun 30, 2024
ALPHAMARK ADVISORS, LLC0.01%0.12%1,9221,922100.00%353,000Jun 30, 2024
ALGERT GLOBAL LLC0.01%0.01%1,8531,853100.00%340,000Jun 30, 2024
CROSSMARK GLOBAL HOLDINGS, INC.0.01%0.01%1,7371,737100.00%319,000Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)0.01%0.00%1,6051,605100.00%294,742Jun 30, 2024
WALLEYE CAPITAL LLC0.00%0.00%1,4001,400100.00%257,096Jun 30, 2024
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC0.00%0.00%1,3741,374100.00%252,321Jun 30, 2024
CIBC ASSET MANAGEMENT INC0.00%0.00%1,3631,363100.00%250,301Jun 30, 2024
NEBULA RESEARCH & DEVELOPMENT LLC0.00%0.04%1,1921,192100.00%218,899Jun 30, 2024
CORTON CAPITAL INC.0.00%0.11%1,0991,099100.00%201,820Jun 30, 2024
KEY FINANCIAL INC0.00%0.01%151151100.00%27,730Jun 30, 2024
JAMISON PRIVATE WEALTH MANAGEMENT, INC.0.00%0.00%150150100.00%27,546Jun 30, 2024
COPPELL ADVISORY SOLUTIONS LLC0.00%0.00%113113100.00%20,751Jun 30, 2024
BESSEMER GROUP INC0.00%-4040100.00%7,000Jun 30, 2024
FIFTH THIRD BANCORP0.00%-3838100.00%6,978Jun 30, 2024
ASHTON THOMAS PRIVATE WEALTH, LLC0.00%0.00%3838100.00%6,978Jun 30, 2024
UMB BANK, N.A.0.00%0.00%2626100.00%4,775Jun 30, 2024
CULLEN/FROST BANKERS, INC.0.00%0.00%2424100.00%4,407Jun 30, 2024
FARMERS & MERCHANTS INVESTMENTS INC0.00%0.00%1515100.00%2,755Jun 30, 2024
ITAU UNIBANCO HOLDING S.A.-0.00%1414100.00%2,571Jun 30, 2024
INNEALTA CAPITAL, LLC-0.00%1414100.00%2,571Jun 30, 2024
GLEN EAGLE ADVISORS, LLC-0.00%55100.00%918Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC--44100.00%765Jun 30, 2024
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC-0.00%44100.00%735Jun 30, 2024
PARKSIDE FINANCIAL BANK & TRUST-0.00%22100.00%368Jun 30, 2024
-0.00%11100.00%184Jun 30, 2024

Krystal Biotech's largest new institutional shareholder by number of shares is EAGLE ASSET MANAGEMENT INC, purchased 76.26K shares, valued at $13.90M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
IKARIAN CAPITAL, LLC----375,000-100.00%-Jun 30, 2024
VESTAL POINT CAPITAL, LP----45,000-100.00%-Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC----26,746-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----24,700-100.00%-Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC----24,000-100.00%-Jun 30, 2024
J. GOLDMAN & CO LP----20,963-100.00%-Jun 30, 2024
BARCLAYS PLC----20,000-100.00%-Jun 30, 2024
STEMPOINT CAPITAL LP----20,000-100.00%-Jun 30, 2024
EVERSEPT PARTNERS, LP----18,557-100.00%-Jun 30, 2024
TREK FINANCIAL, LLC----16,684-100.00%-Jun 30, 2024
EXOME ASSET MANAGEMENT LLC----14,700-100.00%-Jun 30, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP----14,127-100.00%-Jun 30, 2024
TREXQUANT INVESTMENT LP----13,293-100.00%-Jun 30, 2024
UBS OCONNOR LLC----12,000-100.00%-Jun 30, 2024
CAPITAL FUND MANAGEMENT S.A.----10,978-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----10,652-100.00%-Jun 30, 2024
SILVERARC CAPITAL MANAGEMENT, LLC----10,000-100.00%-Jun 30, 2024
JUMP FINANCIAL, LLC----9,875-100.00%-Jun 30, 2024
HRT FINANCIAL LP----8,536-100.00%-Jun 30, 2024
OMERS ADMINISTRATION CORP----8,200-100.00%-Jun 30, 2024
HARBOR CAPITAL ADVISORS, INC.----7,757-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----7,189-100.00%-Jun 30, 2024
FORA CAPITAL, LLC----5,936-100.00%-Jun 30, 2024
MARSHALL WACE, LLP----5,600-100.00%-Jun 30, 2024
CAPITAL IMPACT ADVISORS, LLC----5,343-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----4,523-100.00%-Jun 30, 2024
HIGHVISTA STRATEGIES LLC----3,923-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----3,599-100.00%-Jun 30, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----3,403-100.00%-Jun 30, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC----2,479-100.00%-Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.----2,296-100.00%-Jun 30, 2024
GTS SECURITIES LLC----2,200-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----1,800-100.00%-Jun 30, 2024
HEADLANDS TECHNOLOGIES LLC----1,636-100.00%-Jun 30, 2024
TORNO CAPITAL, LLC----1,500-100.00%-Jun 30, 2024
SCIENTECH RESEARCH LLC----1,367-100.00%-Jun 30, 2024
WALLEYE TRADING LLC----1,200-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.----1,192-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----1,136-100.00%-Jun 30, 2024
PEAK6 INVESTMENTS LLC----1,000-100.00%-Jun 30, 2024
AQUATIC CAPITAL MANAGEMENT LLC----1,000-100.00%-Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC----300-100.00%-Jun 30, 2024
IFP ADVISORS, INC----267-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----137-100.00%-Jun 30, 2024
FIRST HORIZON ADVISORS, INC.----24-100.00%-Jun 30, 2024
TFC FINANCIAL MANAGEMENT, INC.----1-100.00%-Jun 30, 2024

Krystal Biotech's largest sold out institutional shareholder by shares sold is IKARIAN CAPITAL, LLC, sold -0.38M shares, valued at -, as of undefined.

Krystal Biotech Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Manager Directed Portfolios1.41%231,162--Jan 31, 2024
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.25%233,261-150,052-39.15%Jan 31, 2024
ALGER FUNDS0.14%136,034-4,190-2.99%Jan 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.12%401,877214,234114.17%Mar 31, 2024
PRUDENTIAL SECTOR FUNDS, INC.0.08%171,917-35,507-17.12%Feb 29, 2024
T. Rowe Price New Horizons Fund, Inc.0.04%206,841--Mar 31, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.0.04%147,134--Mar 31, 2024
Federated Hermes MDT Series0.04%97,173--Jan 31, 2024
ALLSPRING VARIABLE TRUST0.04%22,5304,30023.59%Mar 31, 2024
PRUDENTIAL JENNISON SMALL CO FUND, INC.0.04%154,478-12,565-7.52%Mar 28, 2024
FIDELITY MT VERNON STREET TRUST0.04%1,024,9851,024,985-Feb 29, 2024
OBERWEIS FUNDS0.03%35,70035,700-Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.03%17,347--Mar 31, 2024
T. Rowe Price Quantitative Management Funds, Inc.0.03%105,30021,50025.66%Mar 31, 2024
LORD ABBETT RESEARCH FUND INC0.03%30,676-8,871-22.43%Feb 29, 2024
TEKLA HEALTHCARE INVESTORS0.03%27,13727,137-Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.03%1,985,122--Feb 29, 2024
TEKLA LIFE SCIENCES INVESTORS0.03%11,88711,887-Mar 31, 2024
PRUDENTIAL JENNISON BLEND FUND, INC.0.02%15,1795,28853.46%Feb 29, 2024
EntrepreneurShares Series Trust0.02%5,726--Dec 31, 2023
ALGER INSTITUTIONAL FUNDS0.02%4,836--Jan 31, 2024
ALGER PORTFOLIOS0.02%5,979--Dec 31, 2023
BlackRock Health Sciences Trust0.01%3,123--Mar 31, 2024
Jacob Funds Inc.0.01%2,752-678-19.77%Feb 29, 2024
T. Rowe Price Equity Series, Inc.0.01%18,19512,530221.18%Mar 31, 2024
BlackRock Health Sciences Trust II0.01%26,849--Mar 31, 2024
Voya VARIABLE PRODUCTS TRUST0.01%3,491-167-4.57%Mar 31, 2024
Voya EQUITY TRUST0.01%14,1528946.74%Feb 29, 2024
VICTORY VARIABLE INSURANCE FUNDS0.01%3,850-810-17.38%Mar 31, 2024
FRANKLIN STRATEGIC SERIES0.01%62,400--Jan 31, 2024
T. Rowe Price Equity Funds, Inc.0.01%79,918--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%38,159-1,197-3.04%Mar 31, 2024
SARATOGA ADVANTAGE TRUST0.01%347347-Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%3,230-91-2.74%Mar 31, 2024
LORD ABBETT SECURITIES TRUST0.01%25,653-13,446-34.39%Jan 31, 2024
VANGUARD INDEX FUNDS0.01%2,156,714-384,927-15.14%Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND III0.00%38,10037,7009425.00%Mar 31, 2024
Humankind Benefit Corp0.00%96--Dec 31, 2023
NEUBERGER BERMAN EQUITY FUNDS0.00%41,000--Feb 29, 2024
ROYCE FUND0.00%22,000--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.00%10,6021551.48%Feb 29, 2024
DRIEHAUS MUTUAL FUNDS0.00%23,200-16,010-40.83%Mar 28, 2024
TIAA SEPARATE ACCOUNT VA 10.00%486--Mar 31, 2024
IndexIQ ETF Trust0.00%4,096-244-5.62%Jan 31, 2024
FIDELITY CAPITAL TRUST0.00%19,10019,100-Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND0.00%36,00013,90062.90%Mar 31, 2024
NUVEEN INVESTMENT FUNDS INC0.00%57,54930,366111.71%Jan 31, 2024
VANGUARD HORIZON FUNDS0.00%38,257--Mar 31, 2024
VICTORY PORTFOLIOS0.00%49,610-13,770-21.73%Mar 31, 2024
ALPS ETF Trust0.00%19,777--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%60,717-311-0.51%Jan 31, 2024
Columbia Funds Variable Series Trust II0.00%43,29927,485173.80%Mar 31, 2024
JNL VARIABLE FUND LLC0.00%7,283-2,248-23.59%Mar 31, 2020
FIDELITY CONTRAFUND0.00%81,705--Mar 31, 2024
Mutual of America Variable Insurance Portfolios, Inc.0.00%880111.27%Sep 30, 2023
RYDEX SERIES FUNDS0.00%4,8264,6292349.75%Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%233,31712,2555.54%Feb 29, 2024
MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC0.00%60913227.67%Sep 30, 2020
FORUM FUNDS0.00%2,360--Jan 31, 2024
VANGUARD EXPLORER FUND0.00%12,226--Jan 31, 2024
MUTUAL OF AMERICA INVESTMENT CORP0.00%33,628-1,895-5.33%Mar 31, 2024
FIDELITY SECURITIES FUND0.00%76,639--Jan 31, 2024
Calvert Variable Products, Inc.0.00%2,156-81-3.62%Mar 31, 2024
SMALLCAP WORLD FUND INC0.00%46,14946,149-Mar 31, 2024
Direxion Shares ETF Trust0.00%80,67124,41243.39%Jan 31, 2024
ETFis Series Trust I0.00%706-60-7.83%Jan 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%1,9921,450267.53%Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%14,576-1,160-7.37%Mar 31, 2024
T. Rowe Price Spectrum Funds II, Inc.0.00%6,656--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%476,618127,78436.63%Jan 31, 2024
RYDEX VARIABLE TRUST0.00%5165033869.23%Dec 31, 2023
CARILLON SERIES TRUST0.00%23,46723,467-Mar 31, 2024
Fidelity Commonwealth Trust II0.00%2,738--Aug 31, 2023
Harbor ETF Trust0.00%1,816-107-5.56%Jan 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%18,622--Mar 31, 2024
BNY Mellon Strategic Funds, Inc.0.00%748-4,668-86.19%Feb 29, 2024
ALLSPRING MASTER TRUST0.00%19,037-1,098-5.45%Feb 29, 2024
Ultimus Managers Trust0.00%3,3153,1531946.30%Feb 29, 2024
VANGUARD WORLD FUND0.00%65,9301,0311.59%Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%3,262-9,477-74.39%Mar 31, 2024
AMG FUNDS0.00%7,500-10,600-58.56%Mar 28, 2024
T. Rowe Price Index Trust, Inc.0.00%5,7411152.04%Mar 31, 2024
Principal Exchange-Traded Funds0.00%3,053-250-7.57%Mar 31, 2024
Dimensional ETF Trust0.00%111,2285,4865.19%Jan 31, 2024
ProFunds0.00%2,876-2,014-41.19%Mar 31, 2024
Global X Funds0.00%9,9193703.87%Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%7,116-1,555-17.93%Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%128,5886,7725.56%Feb 29, 2024
CALAMOS INVESTMENT TRUST/IL0.00%22,862-26,964-54.12%Jan 31, 2024
SunAmerica Specialty Series0.00%111--Apr 30, 2021
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,026-43-4.02%Mar 31, 2024
LORD ABBETT SERIES FUND INC0.00%13,560-2,268-14.33%Mar 31, 2024
NEW COVENANT FUNDS0.00%823--Dec 31, 2023
HARBOR FUNDS0.00%4,267-355-7.68%Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%43,627-28,449-39.47%Jan 31, 2024
PUTNAM FUNDS TRUST0.00%36,700--Jan 31, 2024
OHIO NATIONAL FUND INC0.00%2,8201836.94%Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%152,217--Mar 31, 2024
Investment Managers Series Trust II0.00%1,597--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%17,20713,455358.61%Mar 31, 2024

Krystal Biotech's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 231.16K shares, compromising 1.41% of its total assets.

Krystal Biotech Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2494-62.85%
31 Mar, 2425325.25%
31 Dec, 232022.02%
30 Sep, 231981.54%
30 Jun, 2319516.07%
31 Mar, 231685.00%
31 Dec, 221605.26%
30 Sep, 2215210.95%
30 Jun, 22137-0.72%
31 Mar, 22138-9.80%
31 Dec, 2115315.91%
30 Sep, 211328.20%
30 Jun, 211221.67%
31 Mar, 211208.11%
31 Dec, 2011111.00%
30 Sep, 20100-11.50%
30 Jun, 2011325.56%
31 Mar, 2090-
31 Dec, 19905.88%
30 Sep, 198511.84%
30 Jun, 197633.33%
31 Mar, 195726.67%
31 Dec, 1845114.29%
30 Sep, 182123.53%
30 Jun, 181741.67%
31 Mar, 1812-7.69%
31 Dec, 1713-
30 Sep, 1713-

As of 30 Jun 24, 94 institutions are holding Krystal Biotech's shares, representing a decrease of -62.85% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 243,680,532-85.40%
31 Mar, 2425,206,8903.33%
31 Dec, 2324,393,7692.62%
30 Sep, 2323,769,9813.22%
30 Jun, 2323,028,0639.82%
31 Mar, 2320,969,4290.36%
31 Dec, 2220,895,2490.43%
30 Sep, 2220,806,0970.15%
30 Jun, 2220,775,8290.92%
31 Mar, 2220,587,2976.59%
31 Dec, 2119,314,66918.55%
30 Sep, 2116,292,488-0.66%
30 Jun, 2116,400,669-0.45%
31 Mar, 2116,475,46018.42%
31 Dec, 2013,913,094-3.68%
30 Sep, 2014,444,6351.82%
30 Jun, 2014,186,57822.62%
31 Mar, 2011,570,0131.01%
31 Dec, 1911,454,0371.86%
30 Sep, 1911,244,89314.43%
30 Jun, 199,827,30046.36%
31 Mar, 196,714,6678.15%
31 Dec, 186,208,609128.49%
30 Sep, 182,717,29013.68%
30 Jun, 182,390,344-22.30%
31 Mar, 183,076,255-4.95%
31 Dec, 173,236,3492.98%
30 Sep, 173,142,571-

Krystal Biotech (KRYS) has 3.68M shares outstanding as of 30 Jun 24, down -85.40% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2413.01%0.15%
31 Mar, 2492.83%1.23%
31 Dec, 2386.99%1.09%
30 Sep, 2389.17%1.11%
30 Jun, 2389.56%1.35%
31 Mar, 2381.55%1.21%
31 Dec, 2281.97%1.24%
30 Sep, 2281.21%1.23%
30 Jun, 2281.33%1.21%
31 Mar, 2281.97%1.08%
31 Dec, 2186.95%1.62%
30 Sep, 2173.35%1.34%
30 Jun, 2173.86%1.23%
31 Mar, 2177.52%1.55%
31 Dec, 2070.71%1.31%
30 Sep, 2073.41%1.23%
30 Jun, 2077.17%1.74%
31 Mar, 2066.65%1.28%
31 Dec, 1972.03%1.70%
30 Sep, 1965.03%1.42%
30 Jun, 1967.67%3.12%
31 Mar, 1946.57%1.52%
31 Dec, 1855.42%8.47%
30 Sep, 1825.58%4.76%
30 Jun, 1823.18%2.60%
31 Mar, 1829.85%0.82%
31 Dec, 1760.37%1.07%
30 Sep, 1775.13%-

As of 30 Jun 24, Krystal Biotech is held by 13.01% institutional shareholders, representing a 0.15% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2465-50.76%
31 Mar, 2413232.00%
31 Dec, 23100-7.41%
30 Sep, 231081.89%
30 Jun, 2310639.47%
31 Mar, 2376-9.52%
31 Dec, 22846.33%
30 Sep, 227923.44%
30 Jun, 2264-8.57%
31 Mar, 2270-30.00%
31 Dec, 2110053.85%
30 Sep, 2165-7.14%
30 Jun, 2170-2.78%
31 Mar, 217235.85%
31 Dec, 20531.92%
30 Sep, 2052-33.33%
30 Jun, 207862.50%
31 Mar, 204811.63%
31 Dec, 1943-14.00%
30 Sep, 1950-10.71%
30 Jun, 195655.56%
31 Mar, 1936-5.26%
31 Dec, 1838192.31%
30 Sep, 181330.00%
30 Jun, 1810150.00%
31 Mar, 184-50.00%
31 Dec, 178-38.46%
30 Sep, 1713-

65 institutional shareholders have increased their position in KRYS stock as of 30 Jun 24 compared to 132 in the previous quarter (a -50.76% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2419-77.91%
31 Mar, 248626.47%
31 Dec, 236823.64%
30 Sep, 2355-8.33%
30 Jun, 23605.26%
31 Mar, 235716.33%
31 Dec, 224913.95%
30 Sep, 2243-14.00%
30 Jun, 2250-
31 Mar, 2250108.33%
31 Dec, 2124-27.27%
30 Sep, 21336.45%
30 Jun, 21316.90%
31 Mar, 2129-12.12%
31 Dec, 203310.00%
30 Sep, 203036.36%
30 Jun, 2022-24.14%
31 Mar, 2029-6.45%
31 Dec, 193155.00%
30 Sep, 192042.86%
30 Jun, 1914-12.50%
31 Mar, 1916300.00%
31 Dec, 18433.33%
30 Sep, 18350.00%
30 Jun, 182-
31 Mar, 182-
31 Dec, 17--
30 Sep, 17--

19 institutional shareholders have reduced their position in KRYS stock as of 30 Jun 24 compared to 86 in the previous quarter (a -77.91% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2494-62.85%3,680,532-85.40%13.01%0.15%65-50.76%19-77.91%
31 Mar, 2425325.25%25,206,8903.33%92.83%1.23%13232.00%8626.47%
31 Dec, 232022.02%24,393,7692.62%86.99%1.09%100-7.41%6823.64%
30 Sep, 231981.54%23,769,9813.22%89.17%1.11%1081.89%55-8.33%
30 Jun, 2319516.07%23,028,0639.82%89.56%1.35%10639.47%605.26%
31 Mar, 231685.00%20,969,4290.36%81.55%1.21%76-9.52%5716.33%
31 Dec, 221605.26%20,895,2490.43%81.97%1.24%846.33%4913.95%
30 Sep, 2215210.95%20,806,0970.15%81.21%1.23%7923.44%43-14.00%
30 Jun, 22137-0.72%20,775,8290.92%81.33%1.21%64-8.57%50-
31 Mar, 22138-9.80%20,587,2976.59%81.97%1.08%70-30.00%50108.33%
31 Dec, 2115315.91%19,314,66918.55%86.95%1.62%10053.85%24-27.27%
30 Sep, 211328.20%16,292,488-0.66%73.35%1.34%65-7.14%336.45%
30 Jun, 211221.67%16,400,669-0.45%73.86%1.23%70-2.78%316.90%
31 Mar, 211208.11%16,475,46018.42%77.52%1.55%7235.85%29-12.12%
31 Dec, 2011111.00%13,913,094-3.68%70.71%1.31%531.92%3310.00%
30 Sep, 20100-11.50%14,444,6351.82%73.41%1.23%52-33.33%3036.36%
30 Jun, 2011325.56%14,186,57822.62%77.17%1.74%7862.50%22-24.14%
31 Mar, 2090-11,570,0131.01%66.65%1.28%4811.63%29-6.45%
31 Dec, 19905.88%11,454,0371.86%72.03%1.70%43-14.00%3155.00%
30 Sep, 198511.84%11,244,89314.43%65.03%1.42%50-10.71%2042.86%
30 Jun, 197633.33%9,827,30046.36%67.67%3.12%5655.56%14-12.50%
31 Mar, 195726.67%6,714,6678.15%46.57%1.52%36-5.26%16300.00%
31 Dec, 1845114.29%6,208,609128.49%55.42%8.47%38192.31%433.33%
30 Sep, 182123.53%2,717,29013.68%25.58%4.76%1330.00%350.00%
30 Jun, 181741.67%2,390,344-22.30%23.18%2.60%10150.00%2-
31 Mar, 1812-7.69%3,076,255-4.95%29.85%0.82%4-50.00%2-
31 Dec, 1713-3,236,3492.98%60.37%1.07%8-38.46%--
30 Sep, 1713-3,142,571-75.13%-13---

Krystal Biotech Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,100$171.49$188.64K1,611,162
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,882$172.21$324.10K1,609,280
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,318$173.49$228.66K1,607,962
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell4,000$174.83$699.30K1,603,962
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell4,550$175.76$799.69K1,599,412
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell5,705$176.68$1.01M1,593,707
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell5,447$177.68$967.81K1,588,260
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell998$178.36$178.00K1,587,262
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell900$171.40$154.26K1,549,982
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell2,099$172.24$361.53K1,547,883
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,206$173.41$209.14K1,546,677
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,724$174.50$300.83K1,544,953
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell4,975$175.33$872.27K1,539,978
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell5,867$176.38$1.03M1,534,111

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,100$171.49$188.64K1,611,162
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,882$172.21$324.10K1,609,280
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,318$173.49$228.66K1,607,962
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell4,000$174.83$699.30K1,603,962
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell4,550$175.76$799.69K1,599,412
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell5,705$176.68$1.01M1,593,707
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell5,447$177.68$967.81K1,588,260
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell998$178.36$178.00K1,587,262
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell900$171.40$154.26K1,549,982
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell2,099$172.24$361.53K1,547,883
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,206$173.41$209.14K1,546,677
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,724$174.50$300.83K1,544,953
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell4,975$175.33$872.27K1,539,978
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell5,867$176.38$1.03M1,534,111

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 01, 2024Gangolli Julian Sdirector-A-AwardBuy5,000$183.64$918.20K5,000
Jul 01, 2024JANNEY DANIELdirector-A-AwardBuy5,000$183.64$918.20K5,000
Jul 01, 2024Mason Christopherdirector-A-AwardBuy5,000$183.64$918.20K5,000
Jul 01, 2024Mazzacco Catherinedirector-A-AwardBuy5,000$183.64$918.20K5,000
Jul 01, 2024Sutherland Everett Randdirector-A-AwardBuy5,000$183.64$918.20K5,000
Jul 01, 2024ROSSI DINO Adirector-A-AwardBuy5,000$183.64$918.20K5,000
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,100$171.49$188.64K1,611,162
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,882$172.21$324.10K1,609,280
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,318$173.49$228.66K1,607,962
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell4,000$174.83$699.30K1,603,962
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell4,550$175.76$799.69K1,599,412
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell5,705$176.68$1.01M1,593,707
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell5,447$177.68$967.81K1,588,260
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell998$178.36$178.00K1,587,262
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell900$171.40$154.26K1,549,982
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell2,099$172.24$361.53K1,547,883
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,206$173.41$209.14K1,546,677
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell1,724$174.50$300.83K1,544,953
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell4,975$175.33$872.27K1,539,978
Jun 11, 2024Krishnan Sumadirector, 10 percent owner, officer President, R&DS-SaleSell5,867$176.38$1.03M1,534,111

The last insider sell of Krystal Biotech's stock was made by Krishnan Suma on Jun 11 2024, selling 1,100 shares at $171.49 per share (valued at $188.64K).

Krystal Biotech Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202473619.44%
Q1 2024337146.48%
Q4 2023-16-
Q3 2023-20-
Q2 2023146122.95%
Q1 202393228.13%
Q4 2022-18-
Q3 2022-2-
Q2 20227--
Q1 202263200.00%
Q4 2021-3-
Q2 202163200.00%
Q1 20218--
Q4 2020-4-
Q3 2020-7-
Q2 202031323.08%
Q1 202021414.29%
Q4 20191234.35%
Q3 2019-3-
Q2 20191--

7 total buy trades, and 36 total sell trades (buy/sell ratio of 0.19%) were made by Krystal Biotech's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-35-
Q1 2024-53-
Q4 2023-16-
Q3 2023-20-
Q2 2023-56-
Q1 2023-29-
Q4 2022-18-
Q3 2022-2-
Q2 2022---
Q1 2022---
Q4 2021-3-
Q2 2021---
Q1 2021---
Q4 2020---
Q3 2020-7-
Q2 2020-13-
Q1 2020-14-
Q4 2019-22-
Q3 2019-3-
Q2 2019---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 35 open market sell trades of Krystal Biotech's stocks.

Krystal Biotech Peer Ownership


TickerCompany
APLSApellis Pharmaceuticals, Inc.
MGTXMeiraGTx Holdings plc
RGNXREGENXBIO Inc.
DCPHDeciphera Pharmaceuticals, Inc.
RYTMRhythm Pharmaceuticals, Inc.

KRYS Ownership FAQ


Krystal Biotech is owned by institutional shareholders (13.01%), insiders (12.32%), and public (74.68%). The largest institutional shareholder of Krystal Biotech is FMR LLC (15.14% of total shares) and the top mutual fund owner is Manager Directed Portfolios (1.41% of total shares).

Krystal Biotech's major institutional shareholders are FMR LLC, BLACKROCK INC., VANGUARD GROUP INC, AVORO CAPITAL ADVISORS LLC, and STATE STREET CORP. The top five shareholders own together 52.54% of the company's share outstanding.

As of Jun 2024, there are 94 institutional shareholders of Krystal Biotech.

FMR LLC owns 4.28M shares of Krystal Biotech, representing 15.14% of the company's total shares outstanding, valued at $786.67M (as of Jun 2024).

As of Jun 2024, BLACKROCK INC holds 3.95M shares of Krystal Biotech (KRYS), compromising 13.95% of the company, valued at $724.98M.

VANGUARD GROUP INC is the third largest holder of Krystal Biotech. The company owns 2.87M of the company's shares outstanding (worth $526.89M).